Endoglycosidase H (Endo H): Functional Insights, Technological Innovations, and Multidisciplinary Applications

1. Concept

Endoglycosidase H (Endo H) is a specialized glycoside hydrolase that selectively cleaves N-linked glycan chains, emerging as a cornerstone tool in glycoprotein research due to its high catalytic activity, exceptional purity, and broad substrate compatibility. Structurally, it consists of a single polypeptide chain with a molecular weight of approximately 29 kDa, featuring a conserved Asp-Glu catalytic residue pair in its active site. This pair mediates the hydrolysis of β-1,4 glycosidic bonds through an acid-base synergistic mechanism.

Industrially, Endo H is primarily produced via recombinant technology in E. coli or yeast systems, ensuring a purity of ≥95% and freedom from protease contamination. It exhibits strict substrate specificity: it specifically targets the GlcNAc-GlcNAc core structure of high-mannose and hybrid N-glycans, while showing no activity toward complex glycans modified with sialic acid or fucose. Optimal reaction conditions for Endo H are pH 5.5–6.0 and 37°C, with an enzymatic activity of up to 1×10⁶ U/mL, enabling over 90% substrate cleavage within 1 hour.

2. Research Frontiers

Recent research on Endo H has witnessed remarkable advancements driven by enzyme engineering and technological innovation. A key frontier is the development of high-performance variants through directed evolution: the Endo H-Fc mutant, for example, exhibits a threefold increase in catalytic efficiency and expanded substrate recognition, enabling cleavage of some complex glycans. The integrated Fc tag also facilitates magnetic bead-based separation of enzyme-substrate complexes, supporting continuous cascade reactions.

Another breakthrough lies in the discovery and development of extremozymes. ThermoEndo H, isolated from deep-sea hydrothermal vent bacteria, retains stable activity at 65°C, enabling industrial-scale continuous glycan processing. High-temperature reactions reduce steric hindrance caused by glycan refolding, improving cleavage efficiency by 80% compared to mesophilic Endo H. Emerging directions also include the design of multifunctional chimeric enzymes (e.g., fusing Endo H with α-mannosidase for precise glycan trimming) and AI-assisted active site optimization, leveraging deep learning to predict glycan-enzyme binding conformations and enhance catalytic performance. Additionally, efforts are underway to develop Endo H-fluorophore conjugates for in situ labeling, enabling real-time monitoring of intracellular glycan dynamics.

3. Research Significance

Endo H plays an irreplaceable role in advancing glycobiology and translational research. In glycoproteomics, its ability to simplify glycan structures improves mass spectrometry (MS) sensitivity and resolution by 2–3 fold, facilitating the identification of low-abundance glycosylated peptides and glycosylation sites—critical for tumor marker screening and disease mechanism research. In biopharmaceutical development, Endo H addresses the key challenge of glycan heterogeneity in recombinant proteins: it enhances the glycoform homogeneity of therapeutic antibodies (e.g., PD-1 inhibitors) by 60%, reducing batch-to-batch efficacy variability to less than 5% and improving product quality stability.

In structural biology, Endo H treatment reduces glycan complexity of target proteins (e.g., HIV gp120), increasing crystallization success rates by 50% and enabling atomic-resolution structural analysis via cryo-electron microscopy. Its broad compatibility with experimental systems—including direct compatibility with MS preprocessing workflows (no glycerol in storage buffer) and tolerance to 50–200 mM NaCl—further expands its utility across diverse research scenarios, from basic glycobiology studies to industrial biopharmaceutical production.

4. Related Mechanisms, Research Methods, and Product Applications

4.1 Core Catalytic Mechanism

Endo H’s catalytic action relies on the acid-base synergistic effect of the conserved Asp-Glu residue pair in its active site. It specifically recognizes and binds to the GlcNAc-GlcNAc core of high-mannose and hybrid N-glycans, hydrolyzing the β-1,4 glycosidic bond between the two GlcNAc residues. This cleavage releases the glycan chain while leaving a single GlcNAc residue attached to the asparagine (Asn) of the protein backbone, preserving the protein’s structural integrity for downstream analysis.

4.2 Key Functional Advantages and Applications

4.2.1 Deglycosylation and Glycan Homogenization

• Endo H efficiently removes high-mannose glycans from glycoproteins such as antibodies and cell surface receptors, reducing glycosylation-induced molecular heterogeneity. In monoclonal antibody production, it minimizes variability in terminal galactose residues, improving batch-to-batch glycoform consistency by over 40%.

4.2.2 Glycan Structure and Functional Analysis

• Combined with MS and high-performance liquid chromatography (HPLC), Endo H-cleaved glycan fragments enable precise identification of glycosylation sites, branching patterns, and glycoform profiles. This application is particularly valuable in viral research, where Endo H-treated viral envelope protein samples exhibit 98% glycoform resolution.

4.2.3 Multidisciplinary Research Applications

• Glycoproteomics: Enriches high-mannose glycoproteins (e.g., CA125) in tumor marker screening, enabling the identification of low-abundance glycosylated peptides at femtomolar sensitivity via LC-MS/MS.
• Biopharmaceutical Optimization: Enhances the homogeneity and stability of therapeutic proteins, reducing immunogenicity risks and improving clinical efficacy.
• Structural Biology: Simplifies glycoprotein structures to overcome crystallization barriers, facilitating atomic-resolution structural determination of challenging targets.

4.3 Product Support from ANT BIO PTE. LTD.

ANT BIO PTE. LTD. offers a comprehensive portfolio of Endo H and complementary glycobiology tools through its UA sub-brand (specializing in recombinant proteins), tailored to meet diverse research and industrial needs:

• Recombinant Endo H Variants: Including Endo H (UA070040, expressed in E. coli, $60) and Endo H (MBP Tag, UA070042, $80), providing high-purity, active enzymes for glycan cleavage and glycoprotein analysis.
• Complementary Glycosidases: Endo F1 (UA070121, $165), Endo S (UA070039, $225), Endo S2 (UA070055, $480), and Endoproteinase Glu-C (UA070059, $130) for comprehensive N-linked glycan analysis and protein digestion workflows.
• Glycoprotein Standards: Recombinant Endoglin/CD105 proteins (e.g., UA010868, UA010906) with defined glycosylation patterns, enabling validation of Endo H cleavage efficiency and assay calibration.
• Custom Services: Recombinant protein expression, enzyme engineering, and conjugation services (e.g., fluorophore labeling) to develop tailored Endo H variants for specialized applications such as in situ glycan monitoring.

5. Brand Mission

ANT BIO PTE. LTD. is dedicated to empowering life science research and translational innovation through the provision of high-quality, reliable reagents and comprehensive solutions. As a leading provider of life science products, our portfolio spans antibodies, recombinant proteins, kits, and general reagents, with three specialized sub-brands catering to distinct research needs: Absin (general reagents and kits), Starter (antibodies), and UA (recombinant proteins). Our core mission is to accelerate scientific discovery, bridge the gap between basic research and clinical application, and contribute to the advancement of human health by delivering cutting-edge products, professional technical support, and exceptional customer service. We strive to be a trusted partner for researchers and biopharmaceutical developers worldwide, supporting their efforts to unravel glycobiology mysteries and develop innovative therapies.

6. Related Product List (With Product Codes)

7. AI Disclaimer

This article is AI-compiled and interpreted based on the original work. All intellectual property (e.g., images, data) of the original publication shall belong to the journal and the research team. For any infringement, please contact us promptly and we will take immediate action.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.